RayzeBio is developing transformative radiopharmaceutical therapies to improve survival rates for patients with cancer.
Base: $77,846 - $94,332; Bonus/Equity: Additional incentive cash and stock opportunities available; Benefits: Medical, dental, vision, 401(k), paid time off
Must-have
Nice-to-have
Not specified